Clinical Trial Update: VA Dual Sequential Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update noting that VA Dual Sequential Therapy for Helicobacter pylori infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: RECRUITING